CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genstruct, Inc., a systems biology company focused on identifying molecular mechanisms, networks and biomarkers to better develop novel therapeutics, molecular diagnostics and patient-specific therapies, today announced the appointment of Dr. Arnold J. Levine to the company’s Board of Directors where he will help drive Genstruct’s scientific strategy and direction.
